Purine derivatives as A3 receptorselective agonists

Details for Australian Patent Application No. 2009231978 (hide)

Owner The United States of America, as represented by the Secretary, Department of Health and Human Services

Inventors Jacobson, Kenneth A.; Melman, Artem

Agent Fisher Adams Kelly

Pub. Number AU-A-2009231978

PCT Pub. Number WO2009/123881

Priority 61/040,985 31.03.08 US

Filing date 24 March 2009

Wipo publication date 8 October 2009

International Classifications

C07D 473/34 (2006.01) Heterocyclic compounds containing purine ring systems

A61K 31/52 (2006.01)

A61P 3/00 (2006.01) Drugs for disorders of the metabolism

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

A61P 29/00 (2006.01) Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

21 October 2010 Amendment Made

  The nature of the amendment is: Amend title to read Purine derivatives as A3 adenosine receptorselective agonists

21 October 2010 PCT application entered the National Phase

  PCT publication WO2009/123881 Priority application(s): WO2009/123881

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009231981-Orthopaedic implants having selflubricated articulating surfaces designed to reduce wear, corrosion, and ion leaching

2009231967-Hydroxymethyl pyrrolidines as beta 3 adrenergic receptor agonists